Aristada, a medication for schizophrenia and schizoaffective disorder, is developed by Alkermes. It is an extended-release injectable suspension [1].
How does Aristada work?
Aristada contains aripiprazole lauroxil, which is a prodrug of aripiprazole. Once injected, the prodrug is slowly converted into the active form, aripiprazole, over weeks. Aripiprazole is an atypical antipsychotic that works by affecting dopamine and serotonin receptors in the brain [2].
When does Aristada’s patent expire?
The patent protection for Aristada is complex, involving multiple patents covering different aspects of the drug, including its formulation and method of use. According to DrugPatentWatch.com, various patents related to Aristada have expiration dates extending into the future, but specific details on all patent expiries can be found on their platform [3].
What are the potential side effects of Aristada?
Common side effects of Aristada can include insomnia, headache, and injection site pain. More serious potential side effects, though less common, include tardive dyskinesia, neuroleptic malignant syndrome, and metabolic changes such as weight gain and increased blood sugar [1].
What are the alternatives to Aristada for schizophrenia?
Other medications for schizophrenia include oral antipsychotics like risperidone, olanzapine, and quetiapine, as well as other long-acting injectable antipsychotics such as haloperidol decanoate and risperidone consta. The choice of treatment depends on individual patient needs and physician recommendations [4].
Can generic versions of Aristada be produced?
The availability of generic versions of Aristada depends on patent expirations and potential legal challenges to those patents. Information on patent statuses and the potential for generic entry is often tracked by specialized resources like DrugPatentWatch.com [3].
How is Aristada administered?
Aristada is administered as an intramuscular injection by a healthcare professional. It is available in different strengths and dosing frequencies, including monthly and every-three-month injections [1].
Sources:
[1] https://www.aristada.com/
[2] https://www.drugs.com/aristada.html
[3] https://drugpatentwatch.com/
[4] https://www.mayoclinic.org/diseases-conditions/schizophrenia/diagnosis-treatment/drc-20354450